Chemists create two-armed nanorobotic device to maneuver world's tiniest particles

18-Feb-2009 - China

Chemists at New York University and China's Nanjing University have developed a two-armed nanorobotic device that can manipulate molecules within a device built from DNA. The device is described in Nature nanotechnology .

"The aim of nanotechnology is to put specific atomic and molecular species where we want them and when we want them there," said NYU Chemistry Professor Nadrian Seeman, one of the co-authors. "This is a programmable unit that allows researchers to capture and maneuver patterns on a scale that is unprecedented."

The device is approximately 150 x 50 x 8 nanometers. The creation enhances Seeman's earlier work — a single nanorobotic arm, completed in 2006, marking the first time scientists had been able to employ a functional nanotechnology device within a DNA array. The new, two-armed device employs DNA origami, a method unveiled in 2006 that uses a few hundred short DNA strands to direct a very long DNA strand to form structures that adopt any desired shape. These shapes, approximately 100 nanometers in diameter, are eight times larger and three times more complex than what could be created within a simple crystalline DNA array.

As with Seeman's previous creation, the two-armed nanorobotic device enables the creation of new DNA structures, thereby potentially serving as a factory for assembling the building blocks of new materials. With this capability, it has the potential to develop new synthetic fibers, advance the encryption of information, and improve DNA-scaffolded computer assembly.

In the two-armed nanorobotic device, the arms face each other, ready to capture molecules that make up a DNA sequence. Using set strands that bind to its molecules, the arms are then able to change the structure of the device. This changes the sticky ends available to capture a new pattern component.

The researchers note that the device performs with 100 percent accuracy. Earlier trials revealed that it captured targeted molecules only 60 to 80 percent of the time. But by heating the device in the presence of the correct species, they found that the arms captured the targeted molecules 100 percent of the time.

They confirmed their results by atomic force microscopy (AFM), which permits features that are a few billionths of a meter to be visualized.

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

Researchers find possible genetic link for pelvic floor disorders - Gene on chromosome 9 may predispose some women to pelvic floor defects

SYGNIS AG to receive €1.9 million non-dilutive R&D funding from the Spanish government

Chemokine Therapeutics Receives Approval From Hong Kong to Commence Phase II Study in Liver Cancer

New tool for studying magnetic, self-propelled bacteria that resemble compass needles

New tool for studying magnetic, self-propelled bacteria that resemble compass needles

New Biomedical Sciences Executive Committee Established to Lead Phase 2 of Singapore's Biomedical Sciences Initiative

EHEC O104:H4 outbreak event in Germany clarified: sprouts of fenugreek seeds imported from Egypt as underlying cause

Rheumatoid arthritis signaling protein reverses Alzheimer's disease in mouse model - New study shows GM-CSF reduces AD pathology and eliminates memory loss

Aastrom Biosciences and Zellera AG Announce the Initiation of a Clinical Trial for Bone Grafting in Spain - Aastrom's Proprietary TRCs to be Utilized in Second European Clinical Study to Treat Major Bone Fractures

Chemokine Therapeutics achieves critical milestone with the start of a phase Ib/II human clinical trial in cancer

Positive Phase II preliminary results of Validive for the prevention of Severe Oral Mucositis in Head and Neck cancer patients - Improved oral mucositis related symptoms and decreased adverse events related to radiotherapy

Fight against antibiotic-resistant bacteria has a glowing new weapon - A new chemical probe signaling antibiotic resistance risk

Fight against antibiotic-resistant bacteria has a glowing new weapon - A new chemical probe signaling antibiotic resistance risk